12,13)
The C-terminal domain responsible for the epoxide hydrolase activity has been well studied but the N-terminal domain responsible for the phosphatase activity has not.
Angiogenesis is the formation of new blood vessels, in which vascular endothelial growth factor (VEGF) plays a central role. Expression of the VEGF gene is enhanced under hypoxic conditions and controlled primarily by hypoxiainducible factor (HIF)-1.
14) HIF-1 is composed of HIF-1a
and Arnt. 15) Under hypoxia, HIF-1a dimerizes with Arnt and binds to a cognate hypoxia response element (HRE) in the promoter region of genes such as VEGF. Furthermore, CYP2C8/9-derived EETs are involved in the process of angiogenesis under hypoxia. In a model of angiogenesis, an EET antagonist inhibited the formation of tubes induced by the overexpression of CYP2C9, suggesting that CYP2C-derived EETs significantly affect the sequence of angiogenic events under hypoxia. 16) Recently we found that the addition of EETs or overexpression of CYP2C8 in human umbilical artery endothelial cells (HUAECs) and human hepatoma Hep3B cells induced VEGF expression and luciferase promoter activity with HRE. 17) EETs play an important role in the hypoxic response of cells. Hypoxia is essential for cell growth and the metastasis of cancer. Elevated levels of CYP2J2 are found in human cancer tissues and EETs are thought important for the proliferation of cancer cells. 18, 19) Although the cytochrome P450s which produce EETs have been studied extensively, much less is known about the biological significance of the degradation of EETs by sEH.
In this study, we found that expression of sEH was suppressed during hypoxia and that sEH played a critical role in the induction of VEGF expression and cell growth. In addition, we found that the epoxide hydrolase and phosphatase domains of sEH have different biological functions.
MATERIALS AND METHODS

Materials
Fetal bovine serum and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma Chemical (St. Louis, MO, U.S.A.), Isogen from Nippon Gene (Toyama, Japan), Gene Amp Hi Fidelity from Applied Biosystems (Foster City, CA, U.S.A.), Nitro-cellulose membrane and horseradish peroxidase conjugated to goat anti-rabbit IgG from Bio-Rad Laboratories (Hercules, CA, U.S.A.), Dulbecco's modified Eagle's medium and 6-methoxy-2-naphthaldehyde from Wako Pure Chemicals (Tokyo, Japan), Gene Porter 2 from Gene Therapy Systems (San Diego, CA, U.S.A.), and (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxynaphthalen-2-yl)-methyl ester (PHOME) from Cayman Chemical Co. (Ann Arbor, MI, U.S.A.).
Mouse Breeding Male BALB/c mice (7-week-old) were obtained from Japan SLC (Hamamatsu, Japan). All experiments were conducted in accordance with guidelines on the welfare of experimental animals and with the approval of the Ethics Committee on the use of animals of Kwansei Gakuin University. Mice were kept with air (normoxia) or in a hypoxic chamber (10% O 2 ) in which N 2 and air flow were controlled (Yasunaga, Tokyo, Japan) and the oxygen concentration was monitored by an oxygen monitor (Riken Keiki, Tokyo, Japan). Mice were kept in this chamber for 4 d, and killed by decapitation. The livers of control mice (nϭ3) and of hypoxia-treated mice (nϭ3) were perfused by PBS which was preequilibrated in hypoxic chamber. Liver tissue was homogenized in PBS containing protease inhibitors and centrifuged at 10000ϫg. The cell lysate was used for Western blotting. The preparation of tissue was done under normoxia or hypoxia (in the chamber under N 2 ) to avoid oxidative stress. Both preparations gave same results.
Isolation of Human sEH cDNA The entire coding region of human sEH (GenBank accession No. NM_001979) was isolated by polymerase chain reaction (PCR). PCR was performed with Hi Fidelity Taq DNA polymerase as follows: 2 min at 94°C, then 15 s at 94°C, 30 s at 55°C (upstream fragment) or 57°C (downstream fragment), and 1 min at 72°C for 38 cycles. The sEH coding regions comprising a 1.0 kb upstream fragment and 1.0 kb downstream fragment were amplified using primer sets. The primers for the upstream fragment were 5Ј-AAGGATCCGCCATGACGCT-GCGCGCGGC-3Ј (forward primer; underline, BamHI site; double underline, start codon) and 5Ј-AGAAGAGAGCCAT-GTACCAC-3Ј (reverse primer; 1023-1042nd nucleotide). The primers for the downstream fragment were 5Ј-ATCCTG-GTCCAGGACACTGA-3Ј (forward primer; 601-620th nucleotide) and 5Ј-TGAATTCCCGTGGGCACACGCTGCG-TT-3Ј (reverse primer; underline, EcoRI site; stop codon is upstream of this primer). The each amplified DNA was cloned into pGEM by the TA cloning method according to the manufacturer's instructions (Promega). The DNA sequences of upstream and downstream fragments were confirmed by DNA sequence analysis. The upstream of sEH cDNA was digested with BamHI and SspI, and the downstream of sEH cDNA was digested with SspI and EcoRI. These two fragments were ligated into pBluescript II SKϩ (Invitrogen, Carlsbad, CA, U.S.A.) cut with BamHI and EcoRI. The full-length sEH cDNA was cut out with BamHI and EcoRI to construct the sense plasmid or with EcoRI and NotI to construct the antisense plasmid, and then subcloned into pcDNA3.1(ϩ) (Invitrogen), an expression vector for mammalian cells. The resulting plasmid contained sense or antisense sEH cDNA.
Preparation of sEH Mutants The sEH mutant deficient in epoxide hydrolase (EH) activity was prepared by substituting Asp at position 335 with Ser. 20) The mutant cDNA was constructed by PCR with the primer set, 5Ј-AAGGATCCGC-CATGACGCTGCGCGCGGC-3Ј (forward primer 1; underline, BamHI site; double underline, start codon) and 5Ј-ATG-GCCAATGAACACTGCTT-3Ј (reverse primer 2; underline, complementary sequence with primer 3), 5Ј-TGTTCATTG-GCCATAGCTGGGGTGGCATGC-3Ј (forward primer 3; underline, complementary sequence with primer 2; double underline, mutation site) and 5Ј-TGAATTCCCGTGGGCA-CACGCTGCGTT-3Ј (reverse primer 4; underline, EcoRI site). The first half of the mutant was amplified with primers 1 and 2 by PCR and the latter half, with primers 3 and 4. The full-length sEH mutant was amplified from the two fragments with primers 1 and 4 by PCR. The full-length sEH mutant cDNA was cut out with BamHI and EcoRI, and subcloned into pcDNA3.1(ϩ). The DNA sequence of EH mutant was confirmed by DNA sequence analysis. The sEH mutant deficient in phosphatase activity was prepared by replacing Asp at position 9 with Ala. 13) The primers for PCR were 5Ј-GCTGCGCGCGGCCGTCTTCGCCCTTGACGG-3Ј (forward primer 5; underline, BssHII site; double underline, mutation site) and 5Ј-ATACTCGAGCATCTTTGAGACCA-CCGGTG-3Ј (reverse primer 6). The cDNA was cut out with BssHII and HindIII (HindIII site was upstream of primer 6) and inserted into the full-length wild-type sEH cDNA in pCMV, and then subcloned into pcDNA3.1(ϩ). The DNA sequence of phosphatase mutant was confirmed by DNA sequence analysis.
Preparation of Antibodies and Immunoblotting The antibody against human CYP2C8 and human b-actin were prepared in rabbits using a method described previously. 17, 21) The antibody against human sEH was prepared in this study. The full length of human sEH constructed in pBluescript II SKϩ was digested with BamHI and SalI and subcloned into pColdI DNA vector (Takara Bio, Shiga, Japan). sEH protein was expressed in E. coli (BL21 codon plus). E. coli was cultured for 24 h at 15°C. The purity of sEH was not enough when His-tag-fused sEH was purified by Ni-NTA agarose. The expressed sEH was purified by a preparative electrophoresis with Mini Prep Cell (Bio-Rad) according to the manufacturer's instructions. The antibody against human sEH was prepared with rabbits using a method described previously. 22) The female Japanese white rabbit (Shimizu Laboratory Supplies Co., Kyoto, Japan) was immunized with purified sEH protein (50 mg) in Freund's complete adjuvant (Gibco-BRL, Grand Island, NY, U.S.A.). The rabbit was given three boosters of sEH protein (50 mg) from ear vein at 2, 4, and 6 week. Immunoblotting was done with a rabbit anti-sEH, anti-CYP2C8, and anti b-actin antibody as described previously.
23) The intensity of bands was quantified using the NIH Image program.
Cell Cultures and Transfection The human hepatoma cell line Hep3B was obtained from the Cell Resource Center for Biomedical Research at the Institute of Development, Aging and Cancer of Tohoku University, Japan. Hep3B cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Stable transfectants of sEH-overexpressing or knockdown lines were generated from Hep3B cells by transfection of constructs with pcDNA plasmids containing wild-type sEH, antisense sEH, EH mutant, and phosphatase mutant cDNAs (designated, pcDNAWTsEH, pcDNA-asEH, pcDNA-EHmut, and pcDNA-PTmut, respectively). The transfection of each plasmid (7 mg) was done with Gene PORTER TM 2 transfection reagent as described previously. 23) For hypoxic stimulation, the cells were incubated in 5% O 2 , 5% CO 2 and 90% nitrogen with a multi-gas incubator, APM-30D (Astec, Shizuoka, Japan) for 24, 48, and 72 h.
Isolation of RNA and Reverse Transcription-PCR Total RNA was extracted from the tissue of mice or cells with Isogen according to the manufacturer's instructions. Total RNA was converted to cDNA by reverse-transcription as described previously. 24, 25) The cDNA was amplified using the primers shown in Table 1 . PCR with 10 pmol of each primer, 100 ng of cDNA, and Go Taq Green Master Mix (Promega, Madison, WI, U.S.A.), was performed as follows: first 2 min at 94°C and then 30 s at 94°C, 30 s at 55°C, and 30 s at 72°C for the number of cycles indicated in the Table  1 .
Epoxide Hydrolase Activity Assay Epoxide hydrolase (EH) activities of Hep3B overexpressing sEH and mutants were measured by using a fluorescent substrate, PHOME. 26, 27) Cells were washed and scraped in 50 mM Bis Tris-HCl (pH. 7.0) containing protease inhibitors. Cells were sonicated and centrifuged at 100000ϫg. The supernatant (40 mg of protein) was incubated with 25 mM PHOME in 25 mM Bis Tris-HCl (pH 7.0) containing bovine serum albumin (0.1 mg/ml) at room temperature (total volume, 200 ml). Fluorescence was measured every 5 min for 60 min with a Wallac 1420 Multilabel/Luminescence Counter ARVO mx (Perkin Elmer, Foster City, CA, U.S.A.) at excitation wavelength, 330 nm and emission wavelength, 465 nm. The concentration of reaction product, 6-methoxy-2-naphthaldehyde, was determined by calibration curve prepared with authentic 6-methoxy-2-naphthaldehyde.
MTT Assay Cells were plated onto 24-well plate at a density of 1.5ϫ10 4 . After 2 d, 50 ml of a MTT solution (5 mg/ml) was added to the cells. After incubation for 4 h, 500 ml of lysis solution (0.04 N HCl/isopropanol) was added to dissolve the purple formazan crystals, and the optical density (OD) of the wells was measured at 570 nm with background subtracted at 630 nm. The cells were enumerated using a particle counter (Beckman Coulter).
Statistical Analysis Statistical analysis was done with Student's t-test and pϽ0.05 was considered statistically significant.
RESULTS
Immunoblotting of Mouse Liver and Hep3B Cells
First to confirm the specificity of the sEH antibody prepared in this study, mouse liver and Hep3B cell overexpressing sEH were subjected to immunoblotting (Fig. 1) . Mouse liver gave main band and two faint bands (Fig. 1A) . Apparent molecular weight of the main band was calculated as 58 kDa, which is equivalent to that of murine sEH purified previously 28) Hep3B cell gave a band (calculated as 57 kDa) in the similar mobility with mouse sEH (the main band) (Fig.  1B) . The intensity of band of 57 kDa in Hep3B cell increased by overexpression of sEH, indicating that 57 kDa-band is human sEH.
Changes in the Expression of sEH under Hypoxia and VEGF Expression by Knockdown of sEH Mice were kept in a hypoxic chamber (10% O 2 ) for 4 d. The expression of sEH protein was investigated by immunoblotting ( Fig.  2A) . Hypoxia significantly decreased the amount of sEH protein in the mouse liver. The decrease may be regulated at the transcriptional level because the amount of sEH mRNA detected by RT-PCR also decreased under hypoxia (Fig. 2B) . To investigate whether hypoxia directly affects sEH expression, human hepatoma Hep3B cells were cultured under hypoxia and the expression of sEH was measured (Fig. 2C) . After 24 h or 48 h of hypoxia, sEH levels were unchanged. Under these conditions, the expression of a key factor of hypoxia, HIF-1a, is induced and hypoxia response genes such as VEGF are expressed. 14) Prolonged hypoxia for 72 h significantly decreased the level of sEH protein. sEH mRNA expression was also decreased (data not shown). Hypoxia induces the expression of a typical hypoxia-response gene, VEGF. 14) Hypoxia treatment for 72 h induced VEGF mRNA in Hep3B cells (Fig. 2D) . Previously we found that EETs regulated VEGF expression. 17) So, the expression of VEGF was investigated with the knockdown of sEH. The plasmid expressing the antisense RNA of sEH was transfected into Hep3B cells and several clones were selected. Three clones which lack sEH protein were obtained and used in this study. The sEH levels in these cells were detected by Western blotting with anti-sEH antibody. Knockdown of sEH in Hep3B cells markedly induced VEGF expression (Fig. 2E) . siRNA of sEH was also used for knockdown and the same results were obtained (data not shown).
VEGF Expression on Overexpression of sEH and Its Mutants We prepared mutant clones which lacking epoxide hydrolase (EH mutant) or phosphatase (phos mutant) using the amino acid change Asp335Ser or Asp9Ala, respectively. The C-terminal domain has the epoxide hydrolase activity and the N-terminal domain has the phosphatase activity. 12, 13) The activities of these mutants were already confirmed by Pinot et al. 20) and Cronin et al. 13) Overexpression of sEH was performed by transfection with pcDNA including sEH cDNA. The mutants as well as wild-type sEH were overexpressed. First, we measured the EH activities of Hep3B cells, which overexpressed wild sEH, EH mutant, and phosphatase mutant, using a fluorescent substrate, PHOME (Fig. 3A) . As expected, Hep3B cells overexpressing wild type sEH and the phosphatase mutant revealed much higher activity than mock did. The activity of EH mutant was as low as that of mock. Next the expression of VEGF was investigated with the overexpression of sEH. Overexpression of wild-type sEH decreased VEGF expression although effects were small. However, the phosphatase mutant but not epoxide hydrolase mutant did not alter VEGF expression (Fig.  3B) . These results suggest that the phosphatase activity of sEH plays an important role in VEGF expression.
Cell Growth on Overexpression or Knockdown of sEH in Hep3B
It is established that hypoxia promotes the proliferation of vascular endothelial cells or carcinoma cells and that EETs have important effects on cell proliferation. 29) We investigated the effect of overexpression or knockdown of sEH on the growth of Hep3B cells. Hep3B clones in which sEH was overexpressed or knocked down by antisense DNA were isolated and subjected to MTT assays. Optical density at 570 nm was correlated with cell counts made with a Coulter counter (Fig. 4A) . Knockdown of sEH induced MTT activity (Fig. 4B) and overexpression of sEH suppressed MTT activity (Fig. 4C) , suggesting that sEH controls cell growth.
Contribution of the Epoxide Hydrolase and Phosphatase Domains of sEH to Cell Growth
We already found that overexpression of CYP2C8 induces VEGF expression in Hep3B cells under hypoxia. 17) Overexpression of CYP2C8/9 promotes the growth of vascular endothelial cells by enhancing production of EETs. 16) First, cell growth was investigated in Hep3B cells overexpressing CYP2C8 (Fig.  5A) . Overexpression of CYP2C8 did induce cell growth. Next, the wild-type sEH, EH mutant, and phosphatase mutant were overexpressed in Hep3B cells (Fig. 5B) . The expression of the wild type sEH suppressed cell growth. The expression of the EH mutant and phosphatase mutant did not suppress cell growth, suggesting that both the epoxide hydrolase and phosphatase activities are required for the suppression.
DISCUSSION
sEH is a major enzyme involved in the degradation of (A) sEH protein levels in mouse liver exposed to hypoxia. Mice were kept in a hypoxic chamber (10% O 2 ) for 4 d. sEH protein levels in the liver of control mice (nϭ3) and hypoxia-treated mice (nϭ3) were analyzed by Western blotting. (B) sEH mRNA levels in mouse liver exposed to hypoxia. Total RNA was isolated from control mouse liver (nϭ3) and hypoxia-treated mouse liver (nϭ3), and RT-PCR was performed with sEH primers. Amplified DNA fragments were analyzed by electrophoresis with 2% agarose. (C) Expression of sEH protein in Hep3B cells under hypoxia. The cells were cultured under normoxia or hypoxia (5% O 2 ) for 24 (three plates, nϭ3), 48 (nϭ3), and 72 h (nϭ4) and whole cell lysate (40 mg of protein for sEH and 2.5 mg for b-actin) was analyzed by SDS-polyacrylamide gel electrophoresis with a 10% acrylamide gel. (D) Expression of VEGF in Hep3B cells under hypoxia. Hep3B (three plates, nϭ3) was exposed to hypoxia for 72 h and VEGF mRNA level was analyzed by RT-PCR. (E) Effect of knockdown of sEH on VEGF expression. Hep3B cells were lipofected with empty vector (control) or pcDNA-asEH (anti-sense sEH). Several clones were isolated and expression of sEH was confirmed by Western blotting. The expression of VEGF was detected by RT-PCR. The ratio of VEGF mRNA/b-actin mRNA in the control was set at 1. nor, normoxia; hyp, hypoxia; KD, knockdown. Values are the meanϮS.D. for three or four separate samples. * Significantly different from normoxia, pϽ0.05. * * Significantly different from normoxia, pϽ0.01.
Fig. 3. Effects of Overexpression of sEH and Mutants on VEGF Expression
Overexpression of wild-type sEH, epoxide hydrolase-deficient sEH (EH mut), and phosphatase-deficient sEH (phos mut). Hep3B cells were lipofected with empty vector or pcDNA-WTsEH, pcDNA-EHmut, and pcDNA-PTmut. Cells were selected in the presence of G418 and the expression of sEH and mutants was confirmed by Western blotting. Four plates (nϭ4) were used for each group. (A) EH activities of Hep3B cells by using PHOME. Cytosol fractions of cells overexpressing sEH and its mutants were reacted with 25 mM PHOME for 30 min. The graph shows moles of reaction product, MNA, per minute. The production of MNA by autohydrolysis was subtracted from reaction product. ( Overexpression of wild-type sEH, epoxide hydrolase-deficient sEH (EH mut), and phosphatase-deficient sEH (phos mut). Hep3B cells were lipofected with empty vector or pcDNA-WTsEH, pcDNA-EHmut, and pcDNA-PTmut. Cells were selected in the presence of G418 and the expression of sEH and mutants was confirmed by Western blotting. Four plates (nϭ4) were used for each group. The clones expressing sEH or sEH mutants were plated onto 24-well plates at a density of 2.0ϫ10EETs, which is thought to be the major pathway inactivating EETs. Hypoxia regulates a variety of processes including angiogenesis and glucose metabolism, and is critically important to the survival and proliferation of tumor cells. 30) Hypoxia stabilizes a key factor, HIF-1a, which regulates the transcription of several enzymes involved in glucose metabolism and angiogenic factors such as VEGF. 31) Recent studies suggest that epoxygenase metabolites of arachidonic acid, EETs, promote cell proliferation and angiogenesis, and arachidonic acid epoxygenases such as CYP2C8, 2C9, and 2J2 contribute to this process. 18, 19, 29) Michaelis et al. reported that hypoxia induced the expression of CYP2C8/9 and production of EETs. 16) In the present study, we found that hypoxia reduced the expression of sEH in mouse liver and in Hep3B cells, which also may increase the concentration of EETs. In Hep3B cells, it took 72 h for hypoxia to reduce sEH levels. However, the direct application of hydrogen peroxide decreased sEH levels in 4 h (data not shown). At this time, we can not discuss the mechanism regulating the expression of sEH under hypoxia. Active oxygen species such as hydrogen peroxide may contribute to the regulation. The induction of other protein factors may also be required because sEH mRNA expression was suppressed by hypoxia for 72 h.
Recently, sEH was reported to have phosphatase activity as well as epoxide hydrolase activity, 12, 13) but physiological function of the phosphatase activity is unknown. sEH was reported to display phosphatase activity with a generic substrate of phosphatase, 4-nitrophenyl phosphate. 4-Nitrophenyl phosphate does not affect the epoxide hydroxylase activity of sEH and an inhibitor of EH activity does not influence the phosphatase activity, suggesting that these domains do not interact with each other directly. 13) More recently, opposite functions of the phosphatase activity and EH activity were reported in the regulation of cholesterol levels. 32) In the current study, we found that the phosphatase and EH domains were necessary for cell growth whereas the phosphatase domain but not EH domain was necessary for VEGF expression. These findings suggest that the EH activity and phosphatase activity are independent. To our knowledge, the regulation of VEGF expression and cell growth is a new physiological function of the phosphatase activity of sEH.
Newman et al. suggested phospholipids in the sphingosine/ceramide and lipid phosphate phosphatase signaling pathway may be an endogenous substrate for sEH phosphatase. 12) Signaling lipids such as sphingosine control important cellular processes including the proliferation, apoptosis, and migration of cells. 33) These facts and our findings reveal the possibility that sEH plays an important role in cell proliferation and other physiological functions to which phospholipids contribute, although further study to elucidate the physiological function and regulation of sEH is necessary.
